If you thought Johnson & Johnson’s McNeil Labs division — the folks behind all of these recalled over-the-counter drugs — was the only branch of the company capable of creating stinky meds, you were wrong, as J&J has announced a recall of two lots of its prescription anitconvulsant Topamax for that now-classic “uncharacteristic odor.” [More]
